The National Prescribing Centre (NPC) has published MeReC Extra 26 that provides an analysis of the available evidence for rimonobant, a reminder about the national statin policy and pointers to recent MeReC Bulletins.
Individual sections are available as follows:
- Rimonobant for obesity
- National policy for statin prescribing
- MeReC Bulletins and New Medicine Alerts
Action: Clinicians involved in the treatment of obesity or in the prevention and treatment of cardiovascular disease will find this MeReC useful. This publication also provides a pointer to other NPC resources covering contraception, common infection and new drugs.
|« SSRIs and fracture risk||Varenicline reviewed by Cochrane Library »|